Global Dermatologicals Market Statistics, Development and Growth 2021
COVID-19 and lockdown restrictions had conflicting effects on the sales of dermatologicals in 2020. On the one hand, home seclusion and the closure of schools meant consumers spent less time outside and mixing with other people. Thus exposing themselves to less everyday infections and parasites and reducing the need for topical allergy remedies/antihistamines and antiparasitics/lice (head and body) treatments in particular. However, Slovaks were generally confined to their homes for relatively s...
Euromonitor International's Dermatologicals in Slovakia report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2015-2019, allowing you to identify the sectors driving growth. Forecasts to 2024 illustrate how the market is set to change.
Product coverage: Antiparasitics/Lice (Head and Body) Treatments, Antipruritics, Cold Sore Treatments, Haemorrhoid Treatments, Hair Loss Treatments, Medicated Shampoos, Nappy (Diaper) Rash Treatments, Paediatric Dermatologicals, Topical Allergy Remedies/Antihistamines, Topical Antifungals, Topical Germicidals/Antiseptics, Vaginal Antifungals.
Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report?
* Get a detailed picture of the Dermatologicals market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.
Euromonitor International has over 40 years' experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago, Sydney, Tokyo and Bangalore and a network of over 800 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.
Table ofContent
KEY DATA FINDINGS
2020 IMPACT
While lockdown reduces the chance of everyday
infections for a period, rising stress levels provide a boost for hair loss
treatments in 2020
Bayer snaps at the heels of leading GSK
Consumer Healthcare with strong marketing and new products
Rising demand fuels development of new
innovative products
RECOVERY AND OPPORTUNITIES
Health and wellness trends will boost demand
for dermatologicals in the forecast period
Pace of modern life will fuel demand for hair
loss treatments and medicated shampoos in the long-term
Rising disposable incomes over the forecast
period will allow consumers to invest more in dermatologicals
CATEGORY DATA
Table 1 Sales of Dermatologicals by Category:
Value 2015-2020
Table 2 Sales of Dermatologicals by Category: %
Value Growth 2015-2020
Table 3 NBO Company Shares of Dermatologicals:
% Value 2016-2020
Table 4 LBN Brand Shares of Dermatologicals: %
Value 2017-2020
Table 5 LBN Brand Shares of Hair Loss
Treatments: % Value 2017-2020
Table 6 Forecast Sales of Dermatologicals by
Category: Value 2020-2025
Table 7 Forecast Sales of Dermatologicals by
Category: % Value Growth 2020-2025
EXECUTIVE SUMMARY
COVID-19 impact on consumer health
COVID-19 country impact
Company response
Retailing shift
What next for consumer health?
MARKET INDICATORS
Table 8 Consumer Expenditure on Health Goods
and Medical Services: Value 2015-2020
Table 9 Life Expectancy at Birth 2015-2020
MARKET DATA
Table 10 Sales of Consumer Health by Category:
Value 2015-2020
Table 11 Sales of Consumer Health by Category:
% Value Growth 2015-2020
Table 12 NBO Company Shares of Consumer Health:
% Value 2016-2020
Table 13 LBN Brand Shares of Consumer Health: %
Value 2017-2020
Table 14 Penetration of Private Label in Consumer
Health by Category: % Value 2015-2020
Table 15 Distribution of Consumer Health by
Format: % Value 2015-2020
Table 16 Distribution of Consumer Health by
Format and Category: % Value 2020
…... continued
CONTACT
DETAILS :
+44 203 500 2763
+1 62 825 80070
971 0503084105
Comments
Post a Comment